Cannabis
Countdown: Ultra Health to Begin Cannabis Sales to Adults in 100 Days
ALBUQUERQUE, N.M., Dec. 22, 2021 (GLOBE NEWSWIRE) — New Mexico’s adult-use cannabis sales will officially commence in 100 days. Ultra Health, New Mexico’s #1 Cannabis Company, will begin selling cannabis to adults at more than 35 locations come April 1, 2022.
New Mexico’s cannabis legalization enabling legislation, the Cannabis Regulation Act, allows all adults 21 years and older to purchase two ounces of cannabis flower, 16 grams of cannabis extract, and 800 milligrams of edible cannabis at any one time, no later than April 1, 2022.
Despite the rapid approach of the April deadline, the New Mexico Regulation and Licensing Department (RLD) has yet to license enough cannabis producers to meet demand. To date, RLD has licensed just eight additional operators beyond the 34 legacy medical cannabis licensees, according to information published on RLD’s licensing portal.
The eight newly licensed operators include six cannabis producer licensees and two cannabis producer microbusinesses. By statute, microbusinesses are limited to no more than 200 mature cannabis plants.
New Mexico’s legalized cannabis industry will require a minimum of 428,607 plants to be in active production at any one time to meet demand for adults and medical purchasers in 2022. Only 104,105 plants are currently licensed, which is typically a much higher factor than plants in active production, according to information released via Inspection of Public Records requests.
Furthermore, cannabis needs approximately five months to be cultivated and fully prepared for sale. Producers must have been licensed with plants in active production by November 1, 2021, to have cannabis ready for sale on April 1, 2022. Only one of the new operators was licensed by the five-month deadline.
Due to regulatory delays in setting up cannabis producer licensing, medical purchasers and adults will be facing a shortage in the legal cannabis market come April 2022. As demand for cannabis grows, it is unclear when or how a shortage will be mitigated unless RLD allows current producers to ramp up production to meet demand.
Although production levels are inadequate, access to legal cannabis dispensaries will be greater in New Mexico than in other surrounding states.
Today, there are more than 161 retail locations statewide, with 51 in Albuquerque, 20 in Santa Fe, and 10 in Las Cruces. There are just 124 active cannabis dispensaries in Arizona, with 36 in Phoenix proper and 14 in Tucson. Arizona’s total population is over three times New Mexico’s. Arizona regulators limit the number of retail dispensaries but there is no limit in the number of plants a licensee can have in active production to meet demand levels.
Ultra Health is New Mexico’s #1 Cannabis Company and the largest minority-owned cannabis company in the United States. The vertically-integrated provider currently operates 25 dispensary locations statewide, with another 10 stores slated to open by the first quarter of 2022. Ultra Health provides unparalleled medical cannabis care by producing accurately dosed, smokeless cannabis products such as sublingual tablets, oils, pastilles, suppositories and more through its partnership with Israeli pharmaceutical group Panaxia. Ultra Health has been at the forefront of patient-rights issues and continues to fight for adequate supply and rural access in the New Mexico cannabis market.
Contact: Marissa Novel 480-404-6699
[email protected]
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE3 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace